Gary R. Johnson, MS
- 2Articles
- 10.9KReads
- 2018–2020Active
- 19Collaborators
- 17Citations
About
Gary R. Johnson, MS, is affiliated with the VA Connecticut Healthcare System in West Haven, Connecticut. Johnson has published research focused on major depressive disorder (MDD), specifically examining the impact of posttraumatic stress disorder on antipsychotic augmentation outcomes and comparing the cost-effectiveness of aripiprazole augmentation with other depression treatment strategies. His work includes clinical trials conducted between 2018 and 2020. Frequent collaborators include Sidney Zisook, Somaia Mohamed, Alexandra Scrymgeour, Ali Iranmanesh, and Angel Park.
Publications
Cost-Effectiveness of "Next-Step" Depression Treatment Strategies
December 18, 2018
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
